Comparative Pharmacology
Head-to-head clinical analysis: DODEX versus RUBRAMIN PC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DODEX versus RUBRAMIN PC.
DODEX vs RUBRAMIN PC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydroxocobalamin is a synthetic form of vitamin B12, which acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis.
Cyanocobalamin (vitamin B12) is essential for DNA synthesis, myelin formation, and hematopoiesis. It acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase.
1 mg intramuscularly once every 7-10 days for maintenance; 1 mg intramuscularly once daily for 7 days for initial treatment.
1000 mcg intramuscularly once daily for 5-7 days, then 1000 mcg intramuscularly once weekly for 4 weeks, followed by 1000 mcg intramuscularly once monthly.
None Documented
None Documented
Terminal elimination half-life is approximately 6 days (range 4-10 days) in plasma; however, due to extensive tissue binding and enterohepatic recirculation, the pharmacodynamic half-life for correction of deficiency is about 1 year.
Terminal elimination half-life: 6-7 hours in normal renal function; prolonged to 7-10 hours in elderly; significantly extended in renal impairment (up to 80 hours in ESRD), requiring dose adjustment
Primarily renal: ~50-80% of absorbed dose excreted unchanged in urine via glomerular filtration. Biliary/fecal excretion accounts for <10% as cyanocobalamin.
Renal: 50-98% as unchanged drug via glomerular filtration and tubular secretion; biliary/fecal: <1%
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement